Insider at DGX (NYSE: DGX) plans sale of 1,600 common shares

Rhea-AI Filing Summary

DGX has a beneficial owner planning to sell common stock through Fidelity Brokerage Services LLC. The plan covers 1,600 common shares, with an indicated aggregate market value of 376,288.00, to be sold on or after July 28, 2026 on the NYSE. The disclosure also lists future restricted stock vesting events classified as compensation, including tranches of 400, 553, and 647 common shares scheduled to vest on February 12, 14, and 23, 2026, respectively.

Key Figures

Planned shares to be sold: 1,600 shares Aggregate market value: 376,288.00 Planned sale date: 07/28/2026 +3 more

6 metrics

Planned shares to be sold 1,600 shares Common stock to be sold through Fidelity Brokerage Services LLC

Aggregate market value 376,288.00 Approximate value of 1,600 common shares planned for sale

Planned sale date 07/28/2026 Date associated with planned NYSE sale of common shares

Restricted stock vesting tranche 1 400 shares Common shares vesting on 02/12/2026 as compensation

Restricted stock vesting tranche 2 553 shares Common shares vesting on 02/14/2026 as compensation

Restricted stock vesting tranche 3 647 shares Common shares vesting on 02/23/2026 as compensation

Key Terms

Form 144, Restricted Stock Vesting, Compensation

3 terms

Form 144 regulatory

"Filer Information | | | 144: Filer Information"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

Restricted Stock Vesting financial

"Common | 02/12/2026 | Restricted Stock Vesting | Issuer"

Restricted stock vesting is the timetable and conditions under which shares granted to employees or insiders become fully owned and can be sold, typically requiring continued work or meeting performance goals. It matters to investors because large blocks of shares can become tradable at once, which can change share supply and price, and because vesting aligns insiders’ incentives with the company’s long‑term performance—think of it like a timed unlock that both rewards and locks in key people.

Compensation financial

"02/12/2026 | Compensation Common | 02/14/2026"

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 07/28/2026 - 09:46 AM Accepted by SEC EDGAR 07/28/2026 - 09:46 AM Learn about SEC filing dates

FAQ

What does the DGX Form 144 disclosure show about planned stock sales?

The Form 144 shows a plan to sell 1,600 common shares of DGX through Fidelity Brokerage Services LLC, with an aggregate market value of 376,288.00, expected to be sold on or after July 28, 2026 on the NYSE.

How many DGX shares are covered by the planned sale and what is their value?

The planned sale covers 1,600 DGX common shares with an indicated aggregate market value of 376,288.00. These shares are expected to be sold through Fidelity Brokerage Services LLC on the NYSE on or after July 28, 2026.

Which broker and exchange are involved in the DGX Form 144 planned sale?

The planned DGX share sale will use Fidelity Brokerage Services LLC as broker and is listed for execution on the NYSE. The plan covers 1,600 common shares with an aggregate market value of 376,288.00 as disclosed.

What restricted stock vesting events are disclosed for DGX?

The disclosure lists three restricted stock vesting events: 400 shares vesting on February 12, 2026, 553 shares on February 14, 2026, and 647 shares on February 23, 2026, each categorized as compensation from the issuer.

Are the restricted stock vesting events in the DGX filing related to compensation?

Yes. Each vesting event is labeled Restricted Stock Vesting with a transaction nature of Compensation from the issuer. Scheduled tranches include 400, 553, and 647 common shares on specified February 2026 dates.

When are DGX’s restricted shares scheduled to vest according to this disclosure?

Restricted stock is scheduled to vest in three tranches: 400 shares on February 12, 2026, 553 shares on February 14, 2026, and 647 shares on February 23, 2026, all identified as compensation-related vesting from the issuer.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	1600	376288.00	110373360	07/28/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/12/2026	Restricted Stock Vesting	Issuer			400	02/12/2026	Compensation
Common	02/14/2026	Restricted Stock Vesting	Issuer			553	02/14/2026	Compensation
Common	02/23/2026	Restricted Stock Vesting	Issuer			647	02/23/2026	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)